Takara Bio Inc.
Notice Regarding Cancellation of Treasury Stock
Takara Bio Inc. announced it plans to cancel 300 shares of treasury stock held as of June 15, 2026.
Key Figures
- Scheduled cancellation date: June 15, 2026
- Number of shares to be cancelled: 300 shares (all treasury stock)
- Total number of issued shares: 120,415,600 shares (including treasury stock)
AI要約
Overview of Treasury Stock Cancellation
Takara Bio Inc. resolved at the Board of Directors meeting on April 27, 2026, to cancel treasury stock pursuant to Article 178 of the Companies Act. The shares subject to cancellation are common stock of the company, with the scheduled cancellation date set for June 15, 2026. The cancellation covers all 300 shares of treasury stock held by the company. This cancellation is conditional upon approval of a proposal related to a share consolidation at the Extraordinary General Meeting of Shareholders to be held on May 20, 2026.
Impact on Shareholders and Future Schedule
The cancellation of treasury stock will reduce the total number of issued shares; however, specific dilution rates or impacts on shareholder composition are not detailed in the document. The cancellation is scheduled to be executed on June 15, 2026, following approval at the shareholders meeting, and is positioned as part of a capital policy linked with the share consolidation. Investors should closely monitor the resolutions at upcoming shareholder meetings.
Takara Bio Inc.
Company overview · Stock price · Financial data · All IR
